[Federal Register Volume 72, Number 60 (Thursday, March 29, 2007)]
[Notices]
[Page 14822]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-1548]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute, Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung and Blood Institute
Special Emphasis Panel, Research Project in Drug Therapy.
Date: April 26, 2007.
Time: 10:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person:: Mark Roltsch, PhD, Scientific Review
Administrator, Review Branch/DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7192, Bethesda, MD 20892-7924,
301-435-0287, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Disease Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: March 22, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-1548 Filed 3-28-07; 8:45 am]
BILLING CODE 4140-01-M